Nidhi Nautiyal
Overview
Explore the profile of Nidhi Nautiyal including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
8
Citations
91
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Nautiyal N, Maheshwari D, Kumar D, Rao E, Tripathi D, Kumar S, et al.
Front Immunol
. 2024 Aug;
15:1439510.
PMID: 39188716
Background And Aim: Bone marrow stem cells (BM-SCs) and their progeny play a central role in tissue repair and regeneration. In patients with chronic liver failure, bone marrow (BM) reserve...
2.
Maheshwari D, Kumar D, Jagdish R, Nautiyal N, Hidam A, Kumari R, et al.
Front Immunol
. 2022 Jun;
13:856587.
PMID: 35747140
Objective: The monocyte-macrophage system is central to the host's innate immune defense and in resolving injury. It is reported to be dysfunctional in acute-on-chronic liver failure (ACLF). The disease-associated alterations...
3.
Kumar D, Maheshwari D, Nautiyal N, Shubham S, Rooge S, Anand L, et al.
Am J Stem Cells
. 2022 Mar;
11(1):12-27.
PMID: 35295591
Objectives: Cellular and functional exhaustion of bone marrow mesenchymal stem cells (BM-MSC) is significantly associated with the loss of HSCs and hepatic osteodystrophy in cirrhosis. The molecular mechanisms underlying the...
4.
Gupta S, Pinky , Vishal , Sharma H, Soni N, Rao E, et al.
Stem Cell Rev Rep
. 2021 Dec;
18(3):1097-1112.
PMID: 34859376
Mesenchymal Stem Cells (MSCs) derived Extracellular Vesicles (EVs) have emerged as an effective candidate for amelioration of liver fibrosis. However, the effect and the mechanisms of MSC-EVs in liver repair...
5.
Nautiyal N, Maheshwari D, Tripathi D, Kumar D, Kumari R, Gupta S, et al.
Hepatol Int
. 2021 Aug;
15(6):1389-1401.
PMID: 34435344
Background And Aims: Acute-on-chronic liver failure (ACLF) is a distinct clinical entity with high probability of organ failure and mortality. Since patients generally present late, experimental models are needed to...
6.
Baweja S, Bihari C, Negi P, Thangariyal S, Kumari A, Lal D, et al.
Liver Int
. 2021 Mar;
41(7):1614-1628.
PMID: 33713381
Background: Sepsis is common in cirrhosis and is often a result of immune dysregulation. Specific stimuli and pathways of inter-cellular communications between immune cells in cirrhosis and sepsis are incompletely...
7.
Maiwall R, Bajpai M, Singh A, Agarwal T, Kumar G, Bharadwaj A, et al.
Clin Gastroenterol Hepatol
. 2021 Feb;
20(4):e831-e854.
PMID: 33524593
Background: High volume plasma-exchange (HVPE) improves survival in patients with acute liver failure (ALF), but apprehension regarding volume overload and worsening of cerebral edema remain. Methods: In an open-label randomized...
8.
Shubham S, Kumar D, Rooge S, Maras J, Maheshwari D, Nautiyal N, et al.
Hepatol Int
. 2019 Sep;
13(6):777-787.
PMID: 31515741
Background And Aim: Acute hepatic insult triggers regeneration. If acute-on-chronic liver failure (ACLF) patients have a poorer regenerative response than acute liver failure (ALF) patients, and if so, the mechanisms...